Editorials

Daily Editorials

Gist of Editorials, 07 July

National Policy for Rare Diseases, 2021 -

General Studies- III (Issues relating to Health)

Recently, Union Health Minister has approved the ‘National Policy for Rare Diseases’, 2021. Patients of rare diseases will now be treated under the Centre’s Ayushman Bharat Scheme.

Highlights of the Policy:

  • Such patients will be provided financial support of up to Rs 20 lakh for their treatment under the Umbrella Scheme of Rashtriya Arogya Nidhi
  • This aid will be provided to patients with only those rare diseases that require a one-time treatment, i.e., diseases listed under Group 1 in the rare disease policy.
  • The beneficiaries will not be limited to BPL families; it would be extended to 40 percent of the population who are eligible under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PMJAY).

Note: this financial support has been proposed under the Umbrella Scheme of Rastriya Arogya Nidhi (RAN) and not the Ayushman Bharat PMJAY.

Objective of the Policy:

    • To lower the high cost of treatment for rare diseases with increased focus on indigenous research.
    • Creation of a national hospital-based registry of rare diseases so that adequate data is available for definition of rare diseases and for research and development.
  • To strengthen tertiary health care facilities for prevention and treatment of rare diseases through designating 8 health facilities as Centre of Excellence.
  • These CoEs will also be provided one-time financial support of up to Rs 5 crores for upgradation of diagnostics facilities.       

What are the ‘Rare disease’? 

WHO defines rare disease as often debilitating lifelong disease or disorder with a prevalence of 1 or less, per 1000 population. 

  • A rare disease, also referred to as an orphan disease, is any disease that affects a small percentage of the population. 
  • Most rare diseases are genetic, and are present throughout a person’s entire life, even if symptoms do not immediately appear.

Classification of Rare diseases:

Under the policy, there are three categories of rare diseases — 

  1. Requiring one-time curative treatment,
  2. Diseases that require long-term treatment but where the cost is low, and 
  3. Those needing long-term treatments with high cost. 

Some of the diseases in the first category include osteopetrosis and immune deficiency disorders, among others.

Common Rare diseases in India:

Primary immunodeficiency disorders, Lysosomal storage disorders (Gaucher’s disease, Mucopolysaccharidoses, Pompe disease, fabry disease etc.) small molecule inborn errors of metabolism (Maple Syrup urine disease, organic acidemias, etc.), cystic fibrosis, osteogenesis imperfecta, certain forms of muscular dystrophies, and spinal muscular atrophy.

Need of a Policy:

  • The field of rare diseases is very complex and heterogeneous and prevention, treatment and management of rare diseases has multiple challenges. 
  • Early diagnosis of rare diseases is a major challenge owing to a variety of factors that include lack of awareness among primary care physicians, lack of adequate screening and diagnostic facilities etc.

Source: Indian express

Latest Courses

Under The Guidance of Ravika Purohit

Under The Guidance of Mridul Purohit

Under The Guidance of Mridul Purohit

Under The Guidance of Mridul Purohit

For Daily Updates